Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit

被引:71
作者
Buckley, Mitchell S. [1 ]
LeBlanc, Jaclyn M. [2 ]
Cawley, Michael J. [3 ]
机构
[1] Banner Good Samaritan Med Ctr, Dept Pharm, Phoenix, AZ 85006 USA
[2] St Johns Hosp, Dept Pharm, St John, NB, Canada
[3] Univ Sci Philadelphia, Philadelphia Coll Pharm, Philadelphia, PA USA
关键词
hyponatremia; hypernatremia; hypokalemia; hyperkalemia; hypocalcemia; hypercalcemia; hypophosphatemia; hyperphosphatemia; hypomagnesemia; hypermagnesemia; critical illness; water-electrolyte imbalance; NEPHROGENIC DIABETES-INSIPIDUS; HEPARIN-INDUCED HYPERKALEMIA; CRITICALLY-ILL PATIENTS; RENAL TUBULAR-ACIDOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPY; AMPHOTERICIN-B NEPHROTOXICITY; CONVERTING ENZYME-INHIBITORS; DRUG-INDUCED HYPERKALEMIA; CATION-EXCHANGE RESIN; HOSPITALIZED-PATIENTS;
D O I
10.1097/CCM.0b013e3181dda0be
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Electrolyte imbalances are common in critically ill patients. Although multiple disease states typically encountered in the intensive care unit may be responsible for the development of electrolyte disorders, medications may contribute to these disturbances as well. Medications can interfere with the absorption of electrolytes, alter hormonal responses affecting homeostasis, as well as directly impact organ function responsible for maintaining electrolyte balance. The focus on this review is to identify commonly prescribed medications in the intensive care unit and potential electrolyte disturbances that may occur as a result of their use. This review will also discuss the postulated mechanisms associated with these drug-induced disorders. The specific drug-induced electrolyte disorders discussed in this review involve abnormalities in sodium, potassium, calcium, phosphate, and magnesium. Clinicians encountering electrolyte disturbances should be vigilant in monitoring the patient's medications as a potential etiology. Insight into these drug-induced disorders should allow the clinician to provide optimal medical management for the critically ill patient, thus improving overall healthcare outcomes. (Crit Care Med 2010; 38[Suppl.]:S253-S264)
引用
收藏
页码:S253 / S264
页数:12
相关论文
共 169 条
[1]   Hyperkalemia in hospitalized patients -: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines [J].
Acker, CG ;
Johnson, JP ;
Palevsky, PM ;
Greenberg, A .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (08) :917-924
[2]   Primary care -: Hypernatremia [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1493-1499
[3]   DISORDERS OF CALCIUM AND MAGNESIUM HOMEOSTASIS [J].
AGUS, ZS ;
WASSERSTEIN, A ;
GOLDFARB, S .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (03) :473-488
[4]  
Ahmed Emad U., 1998, Journal of the American Society of Nephrology, V9, p103A
[5]   Hypernatremia in the neurologic intensive care unit: how high is too high? [J].
Aiyagari, V ;
Deibert, E ;
Diringer, MN .
JOURNAL OF CRITICAL CARE, 2006, 21 (02) :163-172
[6]   Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole [J].
Alappan, R ;
Perazella, MA ;
Buller, GK .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (03) :316-320
[7]   NEBULIZED ALBUTEROL FOR ACUTE HYPERKALEMIA IN PATIENTS ON HEMODIALYSIS [J].
ALLON, M ;
DUNLAY, R ;
COPKNEY, C .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (06) :426-429
[8]   ALBUTEROL AND INSULIN FOR TREATMENT OF HYPERKALEMIA IN HEMODIALYSIS-PATIENTS [J].
ALLON, M ;
COPKNEY, C .
KIDNEY INTERNATIONAL, 1990, 38 (05) :869-872
[9]   HEPARIN-INDUCED HYPERKALEMIA [J].
AULL, L ;
CHAO, H ;
COY, K .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (03) :244-246
[10]   HYPEROSMOLALITY WITH HYPONATREMIA CAUSED BY INAPPROPRIATE ADMINISTRATION OF MANNITOL [J].
AVIRAM, A ;
PFAU, A ;
CZACZKES, JW ;
ULLMANN, TD .
AMERICAN JOURNAL OF MEDICINE, 1967, 42 (04) :648-&